Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig H Moskowitz

Showing results (11-20 of 143) with videos related to

Pageof 15
Sort By:
Blood|March 4, 2018
Transplant strategies in relapsed/refractory Hodgkin lymphomaGunjan L Shah, Craig H Moskowitz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2021
Autologous Stem Cell Transplantation in the Management of Relapsed Non-Hodgkin LymphomaAlvaro J Alencar, Craig H Moskowitz
The Oncologist|September 10, 2009
Controversies in the treatment of lymphoma with autologous transplantationAlison J Moskowitz, Craig H Moskowitz
Hematology/Oncology Clinics of North America|November 28, 2016
Role of Positron Emission Tomography in Diffuse Large B-cell LymphomaGunjan L Shah, Craig H Moskowitz
Nature Reviews. Clinical Oncology|July 17, 2019
Immune-checkpoint inhibition as first-line therapy for Hodgkin lymphomaAlvaro J Alencar, Craig H Moskowitz
Seminars in Hematology|August 7, 2016
Treatment of relapsed and refractory Hodgkin LymphomaBastian von Tresckow, Craig H Moskowitz
Hemasphere|January 25, 2020
The Role of Autologous Stem Cell Transplantation in the Treatment of Diffuse Large B-cell Lymphoma in the Era of CAR-T Cell TherapyLazaros J Lekakis, Craig H Moskowitz
Journal of the National Comprehensive Cancer Network : JNCCN|March 6, 2010
An update on the role of interim restaging FDG-PET in patients with diffuse large B-cell lymphoma and Hodgkin lymphomaCraig H Moskowitz, Andrew Zelenetz, Heiko Schoder
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 8, 2008
CD5 negative, Cyclin D1-positive diffuse large B-cell lymphoma (DLBCL) presenting as ruptured spleenJulie Teruya-Feldstein, Anuradha Gopalan, Craig H Moskowitz
The Lancet. Oncology|May 7, 2015
PET-adapted salvage therapy for Hodgkin's lymphoma--authors' replyHeiko Schöder, Craig H Moskowitz, Alison J Moskowitz
Pageof 15

Showing results (11-20 of 143) with videos related to

Sort By:
Pageof 15
Blood|March 4, 2018
Transplant strategies in relapsed/refractory Hodgkin lymphomaGunjan L Shah, Craig H Moskowitz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2021
Autologous Stem Cell Transplantation in the Management of Relapsed Non-Hodgkin LymphomaAlvaro J Alencar, Craig H Moskowitz
The Oncologist|September 10, 2009
Controversies in the treatment of lymphoma with autologous transplantationAlison J Moskowitz, Craig H Moskowitz
Hematology/Oncology Clinics of North America|November 28, 2016
Role of Positron Emission Tomography in Diffuse Large B-cell LymphomaGunjan L Shah, Craig H Moskowitz
Nature Reviews. Clinical Oncology|July 17, 2019
Immune-checkpoint inhibition as first-line therapy for Hodgkin lymphomaAlvaro J Alencar, Craig H Moskowitz
Seminars in Hematology|August 7, 2016
Treatment of relapsed and refractory Hodgkin LymphomaBastian von Tresckow, Craig H Moskowitz
Hemasphere|January 25, 2020
The Role of Autologous Stem Cell Transplantation in the Treatment of Diffuse Large B-cell Lymphoma in the Era of CAR-T Cell TherapyLazaros J Lekakis, Craig H Moskowitz
Journal of the National Comprehensive Cancer Network : JNCCN|March 6, 2010
An update on the role of interim restaging FDG-PET in patients with diffuse large B-cell lymphoma and Hodgkin lymphomaCraig H Moskowitz, Andrew Zelenetz, Heiko Schoder
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 8, 2008
CD5 negative, Cyclin D1-positive diffuse large B-cell lymphoma (DLBCL) presenting as ruptured spleenJulie Teruya-Feldstein, Anuradha Gopalan, Craig H Moskowitz
The Lancet. Oncology|May 7, 2015
PET-adapted salvage therapy for Hodgkin's lymphoma--authors' replyHeiko Schöder, Craig H Moskowitz, Alison J Moskowitz
Pageof 15